No Data
No Data
No Data
No Data
No Data
B-SOFT Co.,Ltd. (SZSE:300451) Analysts Are Reducing Their Forecasts For This Year
The latest analyst coverage could presage a bad day for B-SOFT Co.,Ltd. (SZSE:300451), with the analysts making across-the-board cuts to their statutory estimates that might leave shareholders a littl
Simply Wall StApr 17 20:51 ET
Take Care Before Jumping Onto B-SOFT Co.,Ltd. (SZSE:300451) Even Though It's 26% Cheaper
To the annoyance of some shareholders, B-SOFT Co.,Ltd. (SZSE:300451) shares are down a considerable 26% in the last month, which continues a horrid run for the company. The recent drop completes a
Simply Wall StApr 16 20:50 ET
B-SOFT Co.,Ltd. Just Missed EPS By 90%: Here's What Analysts Think Will Happen Next
B-SOFT Co.,Ltd. (SZSE:300451) just released its latest yearly report and things are not looking great. It wasn't a great result overall - while revenue fell marginally short of analyst estimates
Simply Wall StApr 15 19:37 ET
Chuangye Huikang (300451.SZ): 2023 net profit of 366.885 million yuan, plans to distribute 10 to 0.1 yuan
Gelonghui, April 12: Chuanghui Huikang (300451.SZ) announced its 2023 annual report. In 2023, the company achieved operating income of 1,616 billion yuan, an increase of 5.81%; net profit attributable to shareholders of listed companies was 36.6885 million yuan, a year-on-year decrease of 13.93%; net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses was 33.9954 million yuan, a year-on-year decrease of 27.44%; basic income per share was 0.02 yuan; it is intended to distribute a cash dividend of 0.1 yuan (tax included) to all shareholders for every 10 shares.
Gelonghui FinanceApr 12 07:04 ET
B-SOFTLtd (SZSE:300451 Shareholders Incur Further Losses as Stock Declines 5.6% This Week, Taking One-year Losses to 54%
Investing in stocks comes with the risk that the share price will fall. Unfortunately, shareholders of B-SOFT Co.,Ltd. (SZSE:300451) have suffered share price declines over the last year. To wit the
Simply Wall StMar 26 21:10 ET
Chuangye Huikang (300451.SZ): At present, the company's medical device sales business has generated revenue contributions
Gelonghui March 11 丨 An investor asked Chuangye Huikang (300451.SZ) on the investor interactive platform, “Has the company's medical device sales business currently generated revenue? How much impact will it have on the performance growth of listed companies?” The company replied that at present, the company's medical device sales business has generated revenue contributions. For details on the impact on performance, please refer to the disclosure in the company's regular reports.
Gelonghui FinanceMar 11 04:09 ET
No Data
No Data